María-Belén Vidriales
0000-0001-5049-3673
139 papers found
Refreshing results…
Erratum: 'Immunological evaluation of minimal residual disease (MRD) in acute leukaemia (AML)' (Best Practice & Research Clinical Haematology (2002) vol. 15 (1) (112))
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification
Multiparametric analysis of apoptotic and multidrug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia
BIOMED-I concerted action report: Flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings
Apoptotic and multi-drug resistance profile in elderly AML patients: Differences according to the stage of maturation of blast cells
Factors that influence long-term hematopoietic function following autologous stem cell transplantation
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia
Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: Implications for minimal residual disease detection
Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.
Fulminant angiopathy caused by allogenic transplantation of bone marrow with cerebral involvement: clinico-pathologic correlation,Angiopatía fulminante por trasplante alogénico de médula ósea con afectación cerebral: correlación clínico-patológica.
Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics
Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors
Trasplante autólogo con esquema BEAM en linfoma
Controversias en la determinación de CD34
Controversies in the determination of CD34,Controversias en la determinación de CD34.
Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein
Adhesion of multiple myeloma cells to the bone marrow microenvironment: implications for future therapeutic strategies
Transforming growth factor-β1: Differential effects on multiple myeloma versus normal B cells
Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation
Missing publications? Search for publications with a matching author name.